Published in J Control Release on June 23, 2006
Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine (2008) 4.59
Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci (2007) 4.39
Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl (2010) 4.14
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett (2008) 3.20
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm (2008) 2.94
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res (2010) 2.70
Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials (2009) 2.13
Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. Photochem Photobiol (2009) 2.01
Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev (2009) 1.80
SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. Adv Mater (2009) 1.79
Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm (2010) 1.67
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov (2014) 1.61
Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano Lett (2009) 1.57
Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnology (2008) 1.56
Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm (2013) 1.48
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. Nanomedicine (Lond) (2009) 1.44
Detoxification of gold nanorods by treatment with polystyrenesulfonate. ACS Nano (2008) 1.42
Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev (2012) 1.38
Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnology (2010) 1.38
Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Br J Radiol (2010) 1.36
Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater (2010) 1.26
Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via Raman imaging in living mice. ACS Nano (2012) 1.24
Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates. J Am Chem Soc (2011) 1.24
Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv (2012) 1.22
Toxicity and environmental risks of nanomaterials: challenges and future needs. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2009) 1.22
Gold nanoparticles: From nanomedicine to nanosensing. Nanotechnol Sci Appl (2008) 1.21
Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol Med (2010) 1.21
Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. Nano Lett (2010) 1.18
Function of mesenchymal stem cells following loading of gold nanotracers. Int J Nanomedicine (2011) 1.14
Nanoshell-mediated photothermal therapy improves survival in a murine glioma model. J Neurooncol (2010) 1.13
Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. Bioconjug Chem (2009) 1.12
Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer. Int J Nanomedicine (2010) 1.11
Controlled drug delivery systems: past forward and future back. J Control Release (2014) 1.08
Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield. ACS Nano (2012) 1.07
Chemical basis of interactions between engineered nanoparticles and biological systems. Chem Rev (2014) 1.07
Simultaneous enhancement of photothermal stability and gene delivery efficacy of gold nanorods using polyelectrolytes. ACS Nano (2009) 1.05
Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy. Nano Today (2012) 1.05
Gold-Based Magneto/Optical Nanostructures: Challenges for In Vivo Applications in Cancer Diagnostics and Therapy. Mater Res Bull (2009) 1.04
Near-infrared-resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic agent. Small (2010) 1.03
Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441. Part Fibre Toxicol (2009) 1.01
SERS-based plasmonic nanobiosensing in single living cells. Anal Bioanal Chem (2008) 1.01
Gold-loaded polymeric micelles for computed tomography-guided radiation therapy treatment and radiosensitization. ACS Nano (2014) 1.01
Multilayer coating of gold nanorods for combined stability and biocompatibility. Phys Chem Chem Phys (2011) 0.99
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol (2011) 0.98
Nanotechnology in head and neck cancer: the race is on. Curr Oncol Rep (2010) 0.97
125I-labeled gold nanorods for targeted imaging of inflammation. ACS Nano (2011) 0.97
The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. J Control Release (2012) 0.96
Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods. Int J Nanomedicine (2012) 0.96
Three-dimensional optoacoustic imaging as a new noninvasive technique to study long-term biodistribution of optical contrast agents in small animal models. J Biomed Opt (2012) 0.95
Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine (2012) 0.94
Multifunctional photosensitizer-based contrast agents for photoacoustic imaging. Sci Rep (2014) 0.94
Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors. Cancer Res (2014) 0.94
Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns. Cancer Res (2012) 0.94
Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactions. Chem Res Toxicol (2010) 0.93
Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (Lond) (2012) 0.93
Generation and detection of plasmonic nanobubbles in zebrafish. Nanotechnology (2010) 0.90
Functionalized gold nanorods for tumor imaging and targeted therapy. Cancer Biol Med (2012) 0.89
Photoacoustic and ultrasound imaging using dual contrast perfluorocarbon nanodroplets triggered by laser pulses at 1064 nm. Biomed Opt Express (2014) 0.88
Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres. Part Fibre Toxicol (2014) 0.86
Neurological disorders and therapeutics targeted to surmount the blood-brain barrier. Int J Nanomedicine (2012) 0.86
Toxicity and cellular uptake of gold nanorods in vascular endothelium and smooth muscles of isolated rat blood vessel: importance of surface modification. Small (2012) 0.86
Conjugation of antibodies to gold nanorods through Fc portion: synthesis and molecular specific imaging. Bioconjug Chem (2013) 0.85
Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications. Adv Drug Deliv Rev (2011) 0.85
Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell counts. ACS Nano (2011) 0.85
Tumor vascular permeabilization using localized mild hyperthermia to improve macromolecule transport. Nanomedicine (2013) 0.84
Biocompatible Gold Nanorod Conjugates for Preclinical Biomedical Research. J Nanomed Nanotechnol (2012) 0.84
Conversion of rod-shaped gold nanoparticles to spherical forms and their effect on biodistribution in tumor-bearing mice. Nanoscale Res Lett (2012) 0.84
Contrast agents for photoacoustic and thermoacoustic imaging: a review. Int J Mol Sci (2014) 0.83
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer (Auckl) (2015) 0.83
Development of noncytotoxic chitosan-gold nanocomposites as efficient antibacterial materials. ACS Appl Mater Interfaces (2015) 0.83
Highly purified biocompatible gold nanorods for contrasted optoacoustic imaging of small animal models. Nanosci Nanotechnol Lett (2012) 0.83
Laser nanothermolysis of human leukemia cells using functionalized plasmonic nanoparticles. Nano Biomed Eng (2012) 0.83
Laser OptoAcoustic Tomography: Towards New Technology for Biomedical Diagnostics. Nucl Instrum Methods Phys Res A (2013) 0.83
Intravascular photoacoustic imaging of exogenously labeled atherosclerotic plaque through luminal blood. J Biomed Opt (2012) 0.83
Biofunctionalization of Large Gold Nanorods Realizes Ultrahigh-Sensitivity Optical Imaging Agents. Langmuir (2015) 0.83
Echographic detectability of optoacoustic signals from low-concentration PEG-coated gold nanorods. Int J Nanomedicine (2012) 0.82
Protein corona - from molecular adsorption to physiological complexity. Beilstein J Nanotechnol (2015) 0.82
Gold nanoprobes for theranostics. Nanomedicine (Lond) (2011) 0.82
Physical energy for drug delivery; poration, concentration and activation. Adv Drug Deliv Rev (2013) 0.82
Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64. Integr Biol (Camb) (2013) 0.82
Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice. Int J Nanomedicine (2013) 0.82
Anti-Neuroblastoma Activity of Gold Nanorods Bound with GD2 Monoclonal Antibody under Near-Infrared Laser Irradiation. Cancers (Basel) (2011) 0.82
Dual-modality fiber-based OCT-TPL imaging system for simultaneous microstructural and molecular analysis of atherosclerotic plaques. Biomed Opt Express (2015) 0.81
Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo. Sci Rep (2015) 0.81
Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer. MAbs (2011) 0.81
Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayers. Int J Nanomedicine (2011) 0.81
Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinoma. Int J Nanomedicine (2013) 0.81
Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization. Beilstein J Nanotechnol (2015) 0.81
Nanotechnologies for noninvasive measurement of drug release. Mol Pharm (2013) 0.81
Two-photon luminescence properties of gold nanorods. Biomed Opt Express (2013) 0.81
Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars. Nanomedicine (2014) 0.81
Contrast-enhanced optical coherence tomography with picomolar sensitivity for functional in vivo imaging. Sci Rep (2016) 0.80
The gold nanoparticle size and exposure duration effect on the liver and kidney function of rats: In vivo. Saudi J Biol Sci (2013) 0.80
Comparison of behaviour in different liquids and in cells of gold nanorods and spherical nanoparticles modified by linear polyethyleneimine and bovine serum albumin. Biomed Res Int (2014) 0.80
A Dual Gold Nanoparticle System for Mesenchymal Stem Cell Tracking. J Mater Chem B Mater Biol Med (2014) 0.80
Nanopharmacology in translational hematology and oncology. Int J Nanomedicine (2014) 0.80
Gold nanorod biochip functionalization by antibody thiolation. Talanta (2014) 0.80
A histological evaluation and in vivo assessment of intratumoral near infrared photothermal nanotherapy-induced tumor regression. Int J Nanomedicine (2014) 0.80
Tunability and stability of gold nanoparticles obtained from chloroauric Acid and sodium thiosulfate reaction. Nanoscale Res Lett (2012) 0.80
Human exposure to bisphenol A. Toxicology (2006) 2.71
Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir (2006) 1.79
The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release (2009) 1.28
Characterization in vitro and in vivo of the putative multigene 4-coumarate:CoA ligase network in Arabidopsis: syringyl lignin and sinapate/sinapyl alcohol derivative formation. Phytochemistry (2005) 1.15
Controlled release of plasmid DNA from gold nanorods induced by pulsed near-infrared light. Chem Commun (Camb) (2005) 1.15
Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J Control Release (2006) 1.10
De novo sequencing and transcriptome analysis of the central nervous system of mollusc Lymnaea stagnalis by deep RNA sequencing. PLoS One (2012) 1.07
Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase. PLoS Curr (2009) 1.05
Phosphorylation of Rho-associated kinase (Rho-kinase/ROCK/ROK) substrates by protein kinases A and C. Biochimie (2006) 1.04
Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses. J Control Release (2006) 1.02
Association of ambient air pollution and meteorological factors with primary care visits at night due to asthma attack. Environ Health Prev Med (2013) 0.99
Structural advantage of dendritic poly(L-lysine) for gene delivery into cells. Bioorg Med Chem (2006) 0.98
Efficient delivery of siRNA using dendritic poly(L-lysine) for loss-of-function analysis. J Control Release (2007) 0.98
Neural processing of negative word stimuli concerning body image in patients with eating disorders: an fMRI study. Neuroimage (2010) 0.98
Photothermal reshaping of gold nanorods depends on the passivating layers of the nanorod surfaces. Langmuir (2008) 0.95
Stable incorporation of gold nanorods into N-isopropylacrylamide hydrogels and their rapid shrinkage induced by near-infrared laser irradiation. Langmuir (2007) 0.95
Experimentally determined redox potentials of individual (n,m) single-walled carbon nanotubes. Angew Chem Int Ed Engl (2009) 0.95
Controlled-release system of single-stranded DNA triggered by the photothermal effect of gold nanorods and its in vivo application. Bioorg Med Chem (2011) 0.95
The features and shortcomings for gene delivery of current non-viral carriers. Curr Med Chem (2006) 0.95
Poly(ethylene glycol)-modified gold nanorods as a photothermal nanodevice for hyperthermia. J Biomater Sci Polym Ed (2009) 0.95
Preparation of primary amine-modified gold nanoparticles and their transfection ability into cultivated cells. Chem Commun (Camb) (2004) 0.94
Biodegradation or metabolism of bisphenol A: from microorganisms to mammals. Toxicology (2005) 0.94
Surface Analysis of Photolithographic Patterns using ToF-SIMS and PCA. Surf Interface Anal (2009) 0.94
PNIPAM gel-coated gold nanorods for targeted delivery responding to a near-infrared laser. Bioconjug Chem (2009) 0.93
Brain activation during the perception of distorted body images in eating disorders. Psychiatry Res (2010) 0.93
Detection and quantification of on-chip phosphorylated peptides by surface plasmon resonance imaging techniques using a phosphate capture molecule. Anal Chem (2005) 0.93
In vivo siRNA delivery with dendritic poly(L-lysine) for the treatment of hypercholesterolemia. Mol Biosyst (2009) 0.90
Overall interaction of cytosolic proteins with the PEI/DNA complex. J Control Release (2007) 0.89
Protein kinase C (PKC) isozyme-specific substrates and their design. Biotechnol Adv (2012) 0.89
Evaluation of protein kinase activities of cell lysates using peptide microarrays based on surface plasmon resonance imaging. Anal Biochem (2007) 0.88
Immobilized antibody orientation analysis using secondary ion mass spectrometry and fluorescence imaging of affinity-generated patterns. Anal Chem (2010) 0.88
In vivo monitoring of intravenously injected gold nanorods using near-infrared light. Small (2008) 0.88
Affinity-based Protein Surface Pattern Formation by Ligand Self-Selection from Mixed Protein Solutions. Adv Funct Mater (2009) 0.87
Strong micro-dielectric environment effect on the band gaps of (n,m)single-walled carbon nanotubes. J Am Chem Soc (2010) 0.86
Morphology and adhesion strength of myoblast cells on photocurable gelatin under native and non-native micromechanical environments. J Phys Chem B (2013) 0.86
Thermodynamics on soluble carbon nanotubes: how do DNA molecules replace surfactants on carbon nanotubes? Sci Rep (2012) 0.86
Intracellular signal-responsive gene carrier for cell-specific gene expression. Biomacromolecules (2005) 0.86
Psychological and weight-related characteristics of patients with anorexia nervosa-restricting type who later develop bulimia nervosa. Biopsychosoc Med (2008) 0.86
Rational concept to recognize/extract single-walled carbon nanotubes with a specific chirality. J Am Chem Soc (2011) 0.85
Fundamental properties of oligo double-stranded DNA/single-walled carbon nanotube nanobiohybrids. Nanoscale (2010) 0.85
Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier. Mol Pharm (2012) 0.85
Design of polymeric carriers for cancer-specific gene targeting: utilization of abnormal protein kinase Calpha activation in cancer cells. J Am Chem Soc (2008) 0.84
Bisphenol A in the aquatic environment and its endocrine-disruptive effects on aquatic organisms. Crit Rev Toxicol (2007) 0.84
Nanoparticles of adaptive supramolecular networks self-assembled from nucleotides and lanthanide ions. J Am Chem Soc (2009) 0.84
A novel transfection method for mammalian cells using gas plasma. J Biotechnol (2005) 0.84
Gender differences in brain activity generated by unpleasant word stimuli concerning body image: an fMRI study. Br J Psychiatry (2005) 0.84
Conversion of rod-shaped gold nanoparticles to spherical forms and their effect on biodistribution in tumor-bearing mice. Nanoscale Res Lett (2012) 0.84
Polydispersity as a parameter for indicating the thermal stability of proteins by dynamic light scattering. Anal Sci (2010) 0.84
Efficient separation of (6,5) single-walled carbon nanotubes using a "nanometal sinker". Angew Chem Int Ed Engl (2009) 0.83
An intracellular kinase signal-responsive gene carrier for disordered cell-specific gene therapy. J Control Release (2005) 0.83
Molecular design of protein-based nanocapsules for stimulus-responsive characteristics. Bioorg Med Chem (2008) 0.83
Optimal surface chemistry for peptide immobilization in on-chip phosphorylation analysis. Anal Chem (2008) 0.82
A short peptide is a protein kinase C (PKC) alpha-specific substrate. Proteomics (2008) 0.82
Brain activation during the perception of stressful word stimuli concerning interpersonal relationships in anorexia nervosa patients with high degrees of alexithymia in an fMRI paradigm. Psychiatry Res (2012) 0.82
Monitoring protein kinase activity in cell lysates using a high-density peptide microarray. J Biomol Screen (2009) 0.82
Controlled release of PEG chain from gold nanorods: targeted delivery to tumor. Bioorg Med Chem (2010) 0.82
Controlled-release system mediated by a retro Diels-Alder reaction induced by the photothermal effect of gold nanorods. Langmuir (2011) 0.82
A syngeneic hepatocellular carcinoma model rapidly and simply prepared using a hydrodynamics-based procedure. Vet J (2008) 0.82
Specific transgene expression in HIV-infected cells using protease-cleavable transcription regulator. J Control Release (2009) 0.82
Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor. J Gastroenterol Hepatol (2015) 0.81
Protein kinase C alpha-specific peptide substrate graft-type copolymer for cancer cell-specific gene regulation systems. J Control Release (2009) 0.81
Protein-immobilized electrode for rapid and convenient sensing of thyroid hormone receptor-ligand interaction. Anal Sci (2003) 0.81
Near-IR laser-triggered target cell collection using a carbon nanotube-based cell-cultured substrate. ACS Nano (2011) 0.81
Uniform and controllable preparation of Au-Ag core-shell nanorods using anisotropic silver shell formation on gold nanorods. Nanoscale (2010) 0.81
Peptide vector for gene delivery with high affinity for phosphatidylserine. J Pept Sci (2006) 0.81
Characterization of silver ions adsorbed on gold nanorods: surface analysis by using surface-assisted laser desorption/ionization time-of-flight mass spectrometry. Chem Commun (Camb) (2009) 0.81
Inflammatory cell-specific transgene expression system responding to Ikappa-B kinase beta activation. J Gene Med (2009) 0.81
Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling. Neuropharmacology (2006) 0.80
An electrochemical device for the assay of the interaction between a dioxin receptor and its various ligands. Bioorg Med Chem Lett (2004) 0.80
A protein kinase signal-responsive gene carrier modified RGD peptide. Bioorg Med Chem Lett (2006) 0.80
Measurement of homogeneous kinase activity for cell lysates based on the aggregation of gold nanoparticles. Chembiochem (2007) 0.80
Bio and nanotechnological strategies for tumor-targeted gene therapy. Biotechnol Adv (2010) 0.80
Plasma protein kinase C (PKC)alpha as a biomarker for the diagnosis of cancers. Carcinogenesis (2009) 0.80
Rigidity matching between cells and the extracellular matrix leads to the stabilization of cardiac conduction. Biophys J (2012) 0.80
Terminal-functionality effect of poly(N-isopropylacrylamide) brush surfaces on temperature-controlled cell adhesion/detachment. Biomacromolecules (2013) 0.79
Syntheses of structurally-simplified and fluorescently-labeled neovibsanin derivatives and analysis of their neurite outgrowth activity in PC12 cells. Bioorg Med Chem Lett (2012) 0.79
Differences in gene expression profile among SH-SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor. J Neurochem (2005) 0.79
Effective delivery of DNA into tumor cells and tissues by electroporation of polymer-DNA complex. Cancer Lett (2008) 0.79
Peptide substrates for Rho-associated kinase 2 (Rho-kinase 2/ROCK2). PLoS One (2011) 0.79
A novel protease activity assay using a protease-responsive chaperone protein. Biochem Biophys Res Commun (2009) 0.79
A protein kinase assay based on FRET between quantum dots and fluorescently-labeled peptides. Chem Commun (Camb) (2013) 0.79